Occupational Exposure Limits Database

盐酸春雷霉素, KASUGAMYCIN HYDROCHLORIDE HYDRATE, 3-O-[2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-α-D-arabino-hexopyranosyl]-D-chiro-inositol monohydrochloride, MFCD00149375, 1L-1,3,4/2,5,6-1-deoxy-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2,3,4,6-tetradeoxy-4-(α-iminoglycino)-α-D-arabino-hexopyranoside hydrochloride, (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-α-D-arabino-hexopyranoside hydrochloride (1:1), (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-a-D-arabino-hexopyranoside hydrochloride (1:1), KASUGAMYCIN HYDROCHL, kasugamycin,monohydrochloride, a-D-arabino-hexopyranoside, (1a,2b,3a,4a,5b,6b)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-, hydrochloride (1:1), kasugamycin (jmaff), KASUGAMYCIN HCL HYDRATE, kasumin, KasugaMycin HCl, 3-o-[2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-d-arabino-hexopyranosyl]-d-chiro-inositol, Kasugamycin Hydrochloride, [5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyloxy)tetrahydropyran-3-yl]amino-α-iminoacetic acid hydrochloride, α-D-arabino-Hexopyranoside, (1α,2β,3α,4α,5β,6β)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-, hydrochloride (1:1), Kasugamycin hydrochloride from Streptomyces kasugaensis